Surgery Partners, Inc. (SGRY) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
Surgery Partners, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income (loss) → Net cash from operating activities: $27,600,000.00Depreciation and amortization → Operating adjustments reconciliation: $77,800,000.00Non-cash lease expense → Operating adjustments reconciliation: $20,300,000.00Equity-based compensation expense → Operating adjustments reconciliation: $9,600,000.00Net loss on disposals, consolidations and deconsolidations → Operating adjustments reconciliation: $6,700,000.00Non-cash interest expense, net → Operating adjustments reconciliation: $4,500,000.00Equity in earnings of unconsolidated affiliates, net of distributions received → Operating adjustments reconciliation: $1,400,000.00Deferred income taxes → Operating adjustments reconciliation: $900,000.00Operating adjustments reconciliation → Net cash from operating activities: $43,400,000.00Operating adjustments reconciliation → Other operating assets and liabilities: $66,400,000.00Operating adjustments reconciliation → Accounts receivable: $11,400,000.00Other investing activities → investing reconciliation: $7,500,000.00Proceeds from sales of equity investments → investing reconciliation: $900,000.00Proceeds from disposals of facilities and other assets → investing reconciliation: $300,000.00investing reconciliation → Purchases of property and equipment: $37,800,000.00investing reconciliation → Payments for acquisitions, net of cash acquired: $4,100,000.00Net cash used in financing activities → financing reconciliation: $61,000,000.00Borrowings of long-term debt → financing reconciliation: $350,000,000.00Proceeds related to ownership transactions with non-controlling interest holders → financing reconciliation: $3,000,000.00Other financing activities → financing reconciliation: $100,000.00financing reconciliation → Principal payments on long-term debt: $310,200,000.00financing reconciliation → Distributions to non-controlling interest holders: $103,500,000.00financing reconciliation → Payments of debt issuance costs: $400,000.00Net cash used in investing activities → investing reconciliation: $33,200,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $239,900,000.00Net cash from operating activities → Cash sources and uses: $71,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $216,700,000.00Cash sources and uses → Net cash used in investing activities: $33,200,000.00Cash sources and uses → Net cash used in financing activities: $61,000,000.00Other operating assets and liabilities: -$66,400,000.00Other working capital, net−$66.40 MNet loss on disposals, consolidations and deconsolidations: $6,700,000.00Disposal & deconsolidation, net+$6.70 MDepreciation and amortization: $77,800,000.00Depreciation & amortization+$77.80 MAccounts receivable: -$11,400,000.00Accounts receivable−$11.40 MDeferred income taxes: $900,000.00Deferred income taxes+$900.00 KEquity in earnings of unconsolidated affiliates, net of distributions received: $1,400,000.00Equity-method income, net+$1.40 MNon-cash lease expense: $20,300,000.00Non-cash lease expense+$20.30 MEquity-based compensation expense: $9,600,000.00Stock-based compensation+$9.60 MNet income (loss): $27,600,000.00Net income (loss)+$27.60 MNon-cash interest expense, net: $4,500,000.00Non-cash interest expense, net+$4.50 MNet cash from operating activities: $71,000,000.00Operating cash+$71.00 MOperating adjustments reconciliation: $121,200,000.00Principal payments on long-term debt: -$310,200,000.00Long-term debt repaid−$310.20 MBorrowings of long-term debt: $350,000,000.00Long-term debt issued+$350.00 MProceeds related to ownership transactions with non-controlling interest holders: $3,000,000.00Noncontrolling interests, net+$3.00 MOther financing activities: $100,000.00Other financing, net+$100.00 KDistributions to non-controlling interest holders: -$103,500,000.00Noncontrolling dividends−$103.50 MPayments of debt issuance costs: -$400,000.00Debt issuance costs−$400.00 KNet cash used in financing activities: -$61,000,000.00. Cash required to fund net payments.Financing cash−$61.00 Mfinancing reconciliation: $414,100,000.00Purchases of equity investments: $0.00Purchases of property and equipment: -$37,800,000.00PP&E purchases−$37.80 MOther investing activities: $7,500,000.00Other investing, net+$7.50 MPayments for acquisitions, net of cash acquired: -$4,100,000.00Acquisitions, net of cash−$4.10 MProceeds from disposals of facilities and other assets: $300,000.00Asset sales+$300.00 KProceeds from sales of equity investments: $900,000.00Equity-method investment sales+$900.00 KNet cash used in investing activities: -$33,200,000.00. Cash required to fund net payments.Investing cash−$33.20 Minvesting reconciliation: $41,900,000.00Cash sources and uses: $310,900,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $239,900,000.00Beginning cash$239.90 MEnding cash: Cash, cash equivalents, and restricted cash: $216,700,000.00Ending cash$216.70 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$33.20 MOperating cash − cash spent on PP&ECash flow / Net income2.57×Operating cash flow ÷ net incomeNet cash change−$23.20 MEnding cash − beginning cash
Chart details

Surgery Partners, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
239,900,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
71,000,000 US dollars. Net cash provided.
Other operating assets and liabilities
negative 66,400,000 US dollars
Net loss on disposals, consolidations and deconsolidations
6,700,000 US dollars
Depreciation and amortization
77,800,000 US dollars
Accounts receivable
negative 11,400,000 US dollars
Deferred income taxes
900,000 US dollars
Equity in earnings of unconsolidated affiliates, net of distributions received
1,400,000 US dollars
Non-cash lease expense
20,300,000 US dollars
Equity-based compensation expense
9,600,000 US dollars
Net income (loss)
27,600,000 US dollars
Non-cash interest expense, net
4,500,000 US dollars
Investing activities
negative 33,200,000 US dollars. Net cash used.
Purchases of equity investments
0 US dollars
Purchases of property and equipment
negative 37,800,000 US dollars
Other investing activities
7,500,000 US dollars
Payments for acquisitions, net of cash acquired
negative 4,100,000 US dollars
Proceeds from disposals of facilities and other assets
300,000 US dollars
Proceeds from sales of equity investments
900,000 US dollars
Financing activities
negative 61,000,000 US dollars. Net cash used.
Principal payments on long-term debt
negative 310,200,000 US dollars
Borrowings of long-term debt
350,000,000 US dollars
Proceeds related to ownership transactions with non-controlling interest holders
3,000,000 US dollars
Other financing activities
100,000 US dollars
Distributions to non-controlling interest holders
negative 103,500,000 US dollars
Payments of debt issuance costs
negative 400,000 US dollars
Operating adjustment reconciliation
121,200,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
414,100,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
41,900,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
216,700,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
310,900,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 23,200,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.57×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
71,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
37,800,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
33,200,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $43.40M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 71,000,000 US dollars minus 37,800,000 US dollars equals 33,200,000 US dollars.
Surgery Partners, Inc. (SGRY) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!